HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Clinical trials for HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA explained in plain language.
Never miss a new study
Get alerted when new HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA trials appear
Sign up with your email to follow new studies for HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene-Editing shot aims to slash 'Bad' cholesterol for good
Disease control Recruiting nowThis early-phase study tests a single dose of VERVE-102, a gene-editing therapy, in 85 adults with inherited high cholesterol (HeFH) or early heart disease who still need lower LDL cholesterol. The treatment targets the PCSK9 gene in the liver to reduce cholesterol levels. The ma…
Matched conditions: HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Phase: PHASE1 • Sponsor: Verve Therapeutics, Inc. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New cholesterol drug under Real-World watch in spain
Disease control Recruiting nowThis study watches how well the cholesterol-lowering drug inclisiran (Leqvio®) works in everyday medical practice in Spain. It includes 200 adults with heart disease or an inherited form of high cholesterol. The main goal is to see how many patients reach their target LDL cholest…
Matched conditions: HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 11, 2026 20:39 UTC